Literature DB >> 17379323

Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients.

Sophia Steyaert1, Leo Heyndrickx, Lieven Verhoye, Tine Vermoesen, Helen Donners, Katrien Fransen, Filip Van Wanzeele, Beatrijs Vandergucht, Guido Vanham, Geert Leroux-Roels, Peter Vanlandschoot.   

Abstract

Although a limited number of HIV-infected patients have broadly neutralizing antibodies, it has not been examined whether these antibodies can protect against infection with primary virus in vivo. Here we screened the plasma of 23 HIV-1-infected patients for broadly neutralizing antibodies. Purified antibodies from subjects with broad and more narrow responses were administered to huPBL-NOD/Scid mice that were subsequently challenged with primary viruses of clade A, B and CRF01_AE. Although we observed a lack of correlation between the data from the in vitro neutralization assay and the results from the passive immunization experiments, we report for the first time that antibodies from HIV-infected persons can inhibit replication of primary virus isolates in an animal model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379323     DOI: 10.1016/j.antiviral.2006.10.013

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  2 in total

1.  The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection.

Authors:  Sophia Steyaert; Lieven Verhoye; Els Beirnaert; Helen Donners; Katrien Fransen; Leo Heyndrickx; Guido Vanham; Geert Leroux-Roels; Peter Vanlandschoot
Journal:  J Immunol Methods       Date:  2007-01-09       Impact factor: 2.303

2.  A Role for B Cells to Transmit Hepatitis C Virus Infection.

Authors:  Isabelle Desombere; Freya Van Houtte; Ali Farhoudi; Lieven Verhoye; Caroline Buysschaert; Yvonne Gijbels; Sibyl Couvent; Wilfried Swinnen; Hans Van Vlierberghe; André Elewaut; Andrea Magri; Zania Stamataki; Philip Meuleman; Jane A McKeating; Geert Leroux-Roels
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.